|
|
||||||||





*
Department of Allergology and
Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan;
Hijirigaoka Hospital, Tokyo, Japan;
Gunma Prefectural College of Health Science, Maebashi, Japan;
¶
Department of Experimental Immunology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan and Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Tokyo, Japan;
||
Institute of Experimental Animals, Shinshu University School of Medicine, Matsumoto, Japan;
#
Department of Immunology and
**
Intractable Disease Research Center, Tokyo Medical University, Tokyo, Japan; and

The Ogata Institute for Medical & Chemical Research, Tokyo, Japan
Plasmodium berghei XAT is an
irradiation-induced attenuated variant derived from the lethal strain
P. berghei NK65, and its blood-stage parasites are
spontaneously cleared in immune competent mice. In the present study,
we studied the mechanism of host resistance to blood-stage malaria
infection using P. berghei XAT. Infection enhanced
Ab-dependent phagocytosis of PRBC by splenic macrophages in wild-type
C57BL/6 mice. In contrast, FcR
-chain knockout
(FcR
-/-) mice, which lack the ability to mediate
Ab-dependent phagocytosis and Ab-dependent cell-mediated cytotoxicity
through Fc
RI, Fc
RII, and Fc
RIII, could not induce Ab-dependent
phagocytic activity. These FcR
-/- mice showed
increased susceptibility to the P. berghei XAT
infection, with eventually fatal results, although they produced
comparable amounts of IFN-
by spleen cells and anti-XAT Abs in
serum. In addition, passive transfer of anti-XAT IgG obtained from
wild-type mice that had recovered from infection into
FcR
-/- mice could not suppress the increase in
parasitemia, and almost all of these mice died after marked
parasitemia. In contrast, passive transfer of anti-XAT IgG into
control wild-type mice inhibited the increase in parasitemia.
IFN-
-/- mice, which were highly susceptible to the
P. berghei XAT infection, failed to induce Ab-dependent
phagocytic activity and also showed reduced production of serum
anti-XAT IgG2a isotype compared with control wild-type mice. These
results suggest that FcR-mediated Ab-dependent phagocytosis, which is
located downstream of IFN-
production, is important as an effector
mechanism to eliminate PRBC in blood-stage P. berghei
XAT infection.
This article has been cited by other articles:
![]() |
M. R. Clatworthy, L. Willcocks, B. Urban, J. Langhorne, T. N. Williams, N. Peshu, N. A. Watkins, R. A. Floto, and K. G. C. Smith Systemic lupus erythematosus-associated defects in the inhibitory receptor Fc{gamma}RIIb reduce susceptibility to malaria PNAS, April 24, 2007; 104(17): 7169 - 7174. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Owaki, M. Asakawa, S. Kamiya, K. Takeda, F. Fukai, J. Mizuguchi, and T. Yoshimoto IL-27 Suppresses CD28-Medicated IL-2 Production through Suppressor of Cytokine Signaling 3. J. Immunol., March 1, 2006; 176(5): 2773 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Hung, K. R. Seshan, J.-J. Yu, R. Schaller, J. Xue, V. Basrur, M. J. Gardner, and G. T. Cole A Metalloproteinase of Coccidioides posadasii Contributes to Evasion of Host Detection Infect. Immun., October 1, 2005; 73(10): 6689 - 6703. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morishima, T. Owaki, M. Asakawa, S. Kamiya, J. Mizuguchi, and T. Yoshimoto Augmentation of Effector CD8+ T Cell Generation with Enhanced Granzyme B Expression by IL-27 J. Immunol., August 1, 2005; 175(3): 1686 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Scorza, K. Grubb, P. Smooker, A. Rainczuk, D. Proll, and T. W. Spithill Induction of Strain-Transcending Immunity against Plasmodium chabaudi adami Malaria with a Multiepitope DNA Vaccine Infect. Immun., May 1, 2005; 73(5): 2974 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kamiya, T. Owaki, N. Morishima, F. Fukai, J. Mizuguchi, and T. Yoshimoto An Indispensable Role for STAT1 in IL-27-Induced T-bet Expression but Not Proliferation of Naive CD4+ T Cells J. Immunol., September 15, 2004; 173(6): 3871 - 3877. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshimoto, K. Okada, N. Morishima, S. Kamiya, T. Owaki, M. Asakawa, Y. Iwakura, F. Fukai, and J. Mizuguchi Induction of IgG2a Class Switching in B Cells by IL-27 J. Immunol., August 15, 2004; 173(4): 2479 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hisada, S. Kamiya, K. Fujita, M. L. Belladonna, T. Aoki, Y. Koyanagi, J. Mizuguchi, and T. Yoshimoto Potent Antitumor Activity of Interleukin-27 Cancer Res., February 1, 2004; 64(3): 1152 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saeftel, A. Krueger, S. Arriens, V. Heussler, P. Racz, B. Fleischer, F. Brombacher, and A. Hoerauf Mice Deficient in Interleukin-4 (IL-4) or IL-4 Receptor {alpha} Have Higher Resistance to Sporozoite Infection with Plasmodium berghei (ANKA) than Do Naive Wild-Type Mice Infect. Immun., January 1, 2004; 72(1): 322 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |